Latest Industry Insights

Industry Insight
Shaping the Future of Newborn Screening
Dr. Madhuri Hegde discusses Revvity's role in the Generation Study, an ambitious initiative that will sequence the genomes of 100,000 newborns.

Industry Insight
Funding Will Advance Third-Party Verified Sustainability in Science
James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.

Industry Insight
Bacteria-Based Technology Could Revolutionize Solid Tumor Treatment
At the BioTrinity 2025 conference, Technology Networks spoke with Dr. Pedro Correa de Sampaio, co-founder and CEO of Neobe, who are utilizing synthetic biology to engineer bacteria capable of breaking down the barriers within tumors.

Industry Insight
European Consortium Will Advance Long-Read Sequencing in Clinics
A new pan-European network will integrate long-read sequencing into clinical practice, improving diagnosis of rare diseases and cancers.

Industry Insight
Overcoming CAR T-Cell Therapy Limitations
In an interview with Arthur Stril, chief business officer and interim CFO at Cellectis, we explore how gene editing and innovative manufacturing strategies are overcoming the key limitations of autologous CAR T-cell therapy.

Industry Insight
Why Good Science Is Key to Good Technology
In this opinion piece, Philipp Koellinger explores the changes required to level the playing field and accelerate both scientific and technological progress.

Industry Insight
How SPRQ Chemistry Is Breaking Barriers in DNA Sequencing
Dr. Aaron Wenger tells us about SPRQ chemistry, highlighting its unique benefits and role in expanding our understanding of rare diseases.

Industry Insight
Breaking Down Barriers in Multiomic Imaging
Hear from an early user of the neofleXTM MALDI-TOF instrument about how the technology adds new capabilities to MSI workflows.

Industry Insight
The Rise of Cell and Gene Therapies in Treating Complex Diseases
Cell and gene therapies are revolutionizing medicine. Looking to 2025, advancements in allogeneic therapies, streamlined autologous processes and broader applications promise increased accessibility and innovation in treating complex diseases.

Industry Insight
Advancing Public Health With Genomic Insights
Technology Networks spoke with Dr. Mohamed Alameri to explore how population-wide genome initiatives are addressing gaps in genomic data representation and advancing precision medicine in areas such as rare diseases and cancer.
Advertisement